首页> 外文期刊>International journal of molecular medicine >Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices.
【24h】

Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices.

机译:体细胞质量是评估患有肝细胞癌或食管静脉曲张的非腹水性肝硬化患者的营养不良和疾病严重程度的有用参数。

获取原文
获取原文并翻译 | 示例
           

摘要

Body cell mass (BCM) is a nutritional parameter, however, changes in BCM in patients with non-ascitic liver cirrhosis (LC) in comparison to patients with other malnutritional diseases remains unclear. We investigated the difference in BCM between patients with LC and malnourished gastrointestinal disease controls (M.CON), and examined the relationship between BCM and the severity of LC. Results demonstrated that serum nutritional parameters were not significantly different between the LC (n=56) and M.CON groups (n=25), whereas BCM%BW was significantly lower in the LC group than in the M.CON group (50.9+/-4.6 vs. 54.4+/-7.1%, P=0.018). Furthermore, BCM%BW negatively correlated with the model for end-stage liver disease (MELD) score (P=0.04). In concluson, BCM showed a significant decrease and a negative correlation with the MELD score in the LC group. BCM may be a useful parameter for assessing malnutrition and severity of LC.
机译:体细胞量(BCM)是营养参数,但是与其他营养不良疾病患者相比,非腹水性肝硬化(LC)患者的BCM变化尚不清楚。我们调查了LC患者与营养不良的胃肠道疾病对照(M.CON)之间的BCM差异,并研究了BCM与LC严重程度之间的关系。结果表明,LC组(n = 56)和M.CON组(n = 25)的血清营养参数没有显着差异,而LC组的BCM%BW显着低于M.CON组(50.9+ /-4.6与54.4 +/- 7.1%,P = 0.018)。此外,BCM%BW与终末期肝病(MELD)评分模型呈负相关(P = 0.04)。结论是,LC组中BCM与MELD得分显着下降且呈负相关。 BCM可能是评估LC营养不良和严重程度的有用参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号